Royalty Pharma plc

(RPRX) Trade

By |

Profile

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.

Contact Information

Website: www.royaltypharma.com
Email: ir@royaltypharma.com
Main Phone: +1 212 883-0200
Address: 110 East 59th Street
Address 2: FL 33
State: NY
City / Town: New York
Country: USA
Postal Code: 10022

Issuer Information

Exchange: NGS
CEO: Pablo Legorreta
Employees: 35
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

View More

Profile

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.

Contact Information

Website: www.royaltypharma.com
Email: ir@royaltypharma.com
Main Phone: +1 212 883-0200
Address: 110 East 59th Street
Address 2: FL 33
State: NY
City / Town: New York
Country: USA
Postal Code: 10022

Issuer Information

Exchange: NGS
CEO: Pablo Legorreta
Employees: 35
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

View More
$ 45.47 $ -0.007 (-0.02%)
Last Price 45.47 Change $ -0.007 Change % -0.02 Tick N/A
Bid 45.36 Bid Size 200.00 Ask 45.69 Ask Size 100.00
Open 45.11 High 45.62 Low 45.10 Prev Close 45.48
Last Trade Volume 27,905 52 Wk Hi 56.50 52 Wk Low 39.91
Market Cap 27.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 365,899,235.00 EPS (TTM) 2.39 PE Ratio 18.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 12
Number of Buys 0 1
Number of Sells 0 11
Net Activity 0 -294234
Last 10 Buys Shares
Joseph S. Podolski 1,000
Joseph S. Podolski 1,000
Katherine A. Anderson 1,000
Joachim F. Wernicke 1,000
Joachim F. Wernicke 1,000
Joachim F. Wernicke 1,000
Joseph S. Podolski 1,000
Joseph S. Podolski 1,000
Joseph S. Podolski 1,000
Katherine A. Anderson 1,000
Last 10 Sell Shares
Nola E. Masterson 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5.5 5.5 5.5 5.5
Low Target Price Estimate 5.5 5.5 5.5 5.5
Mean Target Price Estimate 5.5 5.5 5.5 5.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/11/17 05/11/17 05/11/17 05/11/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1